Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Evogene Ltd EVGN

Healthcare Biotechnology
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to... see more

Recent & Breaking News (NDAQ:EVGN)

Biomica CEO to Participate in an Industry Panel Discussion at Microbiome Connect USA 2022 Summit

PR Newswire November 14, 2022

Evogene Schedules Third Quarter of 2022 Financial Results Release & Conference Call for November 17, 2022

PR Newswire November 7, 2022

Lavie Bio Advances its Novel Bio-fungicide Program and Applies to the U.S. EPA for Regulatory Approval

PR Newswire October 12, 2022

Evogene to Present at the LD Micro Main Event XV Investor Conference in Los Angeles

PR Newswire October 6, 2022

Canonic Launches its Second-Generation Medical Cannabis Products with High THC and Unique Terpene Profiles

PR Newswire September 21, 2022

Lavie Bio Announces Appointment of Guri Oron as CEO

PR Newswire September 14, 2022

Canonic Advances its Penetration into Europe by Signing its First Licensing Agreement with GroVida

PR Newswire September 13, 2022

ICL and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-Stimulant Products

Business Wire August 16, 2022

Biomica Appoints Professor Gal Markel to Company's Scientific Advisory Board

PR Newswire July 28, 2022

Biomica Announces First Patient Dosed in its Phase I Study of its Microbiome-Based Immuno-Oncology Drug

PR Newswire July 26, 2022

Biomica to Present at the Microbiome Connect Europe 2022

PR Newswire July 5, 2022

Biomica to Present at the 7th Microbiome Movement Drug Development Summit

PR Newswire June 15, 2022

Biomica to Present at the ASCO 2022 Annual Meeting

PR Newswire May 23, 2022

Biomica to Present at the 2022 Digestive Disease Week (DDW) Conference

PR Newswire May 16, 2022

Lavie Bio Announces Successful Product Launch of its Bio-Inoculant result(TM) for the 2022 Spring Wheat Growing Season

PR Newswire May 11, 2022

Biomica Announces Agreement with Sheba Medical Center for Joint Microbiome Clinical Research

PR Newswire April 13, 2022

Canonic Announces Professor Itamar Grotto Joining its Board of Directors

PR Newswire February 16, 2022

Evogene to Present at Aegis Virtual Conference

PR Newswire February 7, 2022

Canonic Announces Shipment of its Cannabis Varieties to Europe

PR Newswire January 31, 2022

Canonic Announces Positive Results in Pre-Clinical Studies in its Precise Product Program for Medical Cannabis

PR Newswire January 18, 2022